| Literature DB >> 33059619 |
Joseph P Erinjeri1, Raphael Doustaly2, Grégoire Avignon2, Achiude Bendet3, Elena N Petre4, Etay Ziv4, Hooman Yarmohammadi4, Stephen B Solomon4.
Abstract
BACKGROUND: Integrated Angiography-Computed Tomography (ACT) suites were initially designed in the 1990's to perform complex procedures requiring high-resolution cross-sectional imaging and fluoroscopy. Since then, there have been technology developments and changes in patient management. The purpose of this study was to review the current usage patterns of a single center's integrated ACT suites.Entities:
Keywords: Angiography-CT; Interventional radiology
Year: 2020 PMID: 33059619 PMCID: PMC7559017 DOI: 10.1186/s12880-020-00515-x
Source DB: PubMed Journal: BMC Med Imaging ISSN: 1471-2342 Impact factor: 1.930
Procedures classification
| 1st/2nd intervention | none | CT | XA | US | CT+ XA |
|---|---|---|---|---|---|
| CT | Standard | Standard | Staged | Standard | Staged + Combined |
| XA | Standard | Staged | Standard | Standard | Staged + Combined |
| US | Standard | Standard | Standard | Standard | Combined |
| CT+ XA | Combined | Staged + Combined | Stage + Combined | Combined | Staged + Combined |
Procedure categories based on the imaging modality combinations of the 1st intervention (1st column) and the 2nd one (1st row). If more than 2 interventions were performed, the same logic was applied. All procedures were classified regardless the use of ultrasound in addition to the other modalities as it’s common practice in interventional radiology and not relevant for the current study
Fig. 1Contribution of each procedure type to the overall number of procedures (a) and total room occupation time (b)
Standard procedures occurrences and average room occupation time
| Procedure description | N | Percent | Room occupation minutes (mean +/−SD) | |
|---|---|---|---|---|
| Drainage, body | 444 | 15.6% | 85 | +/− 44 |
| Biopsy, body | 329 | 11.6% | 80 | +/− 44 |
| Biopsy, spine | 273 | 9.6% | 94 | +/− 34 |
| Biopsy, chest | 257 | 9.0% | 76 | +/− 37 |
| Biliary intervention, stent or catheter placement or conversion to stent | 225 | 7.9% | 112 | +/− 48 |
| Venous intervention | 204 | 7.2% | 132 | +/− 80 |
| Venous access device | 202 | 7.1% | 79 | +/− 30 |
| GU intervention | 181 | 6.4% | 88 | +/− 42 |
| Drainage, chest | 166 | 5.8% | 83 | +/− 41 |
| Arterial intervention (non-liver embolization, arteriogram, stent, pump angio) | 82 | 2.9% | 175 | +/− 75 |
| Biopsy, bone | 69 | 2.4% | 84 | +/− 33 |
| Spine intervention (non-biopsy/aspiration) | 61 | 2.1% | 146 | +/− 47 |
| Biopsy, neuro non-spine | 52 | 1.8% | 83 | +/− 25 |
| Enteral tube placement/exchange | 49 | 1.7% | 106 | +/− 52 |
| Other | 46 | 1.6% | 82 | +/− 25 |
| US Doppler extremity lower vein bilateral | 32 | 1.1% | 74 | +/− 57 |
| Ablation, chest | 29 | 1.0% | 133 | +/− 45 |
| SIRT mapping/treatment | 24 | 0.8% | 125 | +/− 44 |
| Ablation, body | 18 | 0.6% | 173 | +/− 64 |
| Ablation, soft tissue | 11 | 0.4% | 198 | +/− 67 |
| Ablation, bone non-spine | 10 | 0.4% | 131 | +/− 43 |
| Lymphatic intervention | 10 | 0.4% | 220 | +/− 44 |
| Liver embolization | 6 | 0.2% | 212 | +/− 42 |
| Others | 68 | 2.4% | ||
| Total | 2872 | 96 | +/− 53 | |
Combined procedures
| Procedure description | N | Percent | Room occupation minutes (mean +/− SD) | Primary reason for angio | Primary reason for CT | |
|---|---|---|---|---|---|---|
| Drainage, body | 170 | 33% | 95 | +/− 38 | Drain formation check | Abscess access |
| Liver embolization | 132 | 26% | 179 | +/− 61 | Catheter guidance | Post-embolization non-injected CT |
| SIRT mapping/treatment | 90 | 18% | 194 | +/−64 | Catheter guidance | Catheter injected CT for tumor delineation, arterial mapping, extra-hepatic blush identification |
| Arterial intervention (non-liver embolization, arteriogram, stent, pump angio) | 27 | 5% | 187 | +/−70 | Catheter guidance | Catheter injected CT for tumor delineation, arterial mapping, extra-hepatic blush identification |
| Drainage, chest | 26 | 5% | 104 | +/− 51 | Drain formation check | Abscess access |
| Biliary intervention, stent or catheter placement or conversion to stent | 25 | 5% | 143 | +/− 77 | ||
| Enteral tube placement/exchange | 16 | 3% | 125 | +/−98 | ||
| GU intervention, stent or catheter placement/conversion | 8 | 1% | 116 | +/−43 | ||
| Lymphangiogram +/− thoracic duct embolization | 6 | 1% | 225 | +/− 65 | ||
| Others | 14 | 3% | ||||
| Total | 514 | 145 | +/− 70 | |||
Fig. 2Example of CT usage during a Y90 procedure: The patient was a 90 year old female with a history of high-grade leiomyosarcoma of the gastric wall resected 3 years ago. A heterogeneous mass of 4.0 × 3.2 cm appeared in segment 7 on follow-up imaging (a) and the patient was referred to interventional radiology for SIRT Y90 treatment. A catheter- injected CT was performed from the proper hepatic artery, and anatomy was reviewed in reformatted views (b, c). A 3D model of the vessels was automatically generated and vessels were marked with potential MAA injection points (d, arrows), which were then overlaid on the fluoroscopy for guidance (e). An additional catheter-injected CT was performed from the desired location, which was then used to compute the tumor and perfused parenchyma volumes (f). The day of the Y90 treatment, registration of the same dataset using bony landmarks (g) was initially performed and the desired vessel was displayed for guidance (h)
Fig. 3Example of CT usage during a drainage procedure: The patient was a 59 year old female with a postoperative bleed near the pancreatico-gastric anastomosis following liver wedge resection (a). Access from anterior and lateral approaches was not possible because of the left liver (b) and stomach locations (c). Posterior approach was difficult due to the left kidney and splenic arteries. CT (d) was very useful to guide the needle track in 3 dimensions. Once the target had been reached, the operator switched from CT to angiography (e) to set up the drain (f)
Occurrences and average room occupation time for Staged procedures (including Combined and Staged Procedures)
| Procedure description | N | Percent | Room occupation minutes (mean +/−SD) | |
|---|---|---|---|---|
| Multiple collection drains | 43 | 20% | 141 | +/− − 55 |
| Liver embolization + ablation | 26 | 12% | 237 | +/− 73 |
| Liver embolization + biopsy | 25 | 12% | 221 | +/− 56 |
| Kyphoplasty + ablation + biopsy | 19 | 9% | 176 | +/− 27 |
| Venous access + biopsy | 15 | 7% | 126 | +/− 37 |
| Kyphoplasty + biopsy | 10 | 5% | 142 | +/− 56 |
| Biopsy + collection drain | 9 | 4% | 150 | +/− 84 |
| GU intervention + biopsy | 9 | 4% | 133 | +/− 48 |
| GU intervention + collection drainage | 9 | 4% | 136 | +/− 58 |
| Biliary intervention + biopsy | 8 | 3% | 143 | +/− 35 |
| Embolization + biopsy + ablation | 5 | 2% | 303 | +/− 67 |
| Others | 39 | 18% | ||
| Total | 217 | 159 | +/− 64 | |
Fig. 4Example of liver ablation and embolization performed in an ACT room: The patient was a 61 year old male with 2 liver adrenal cortical carcinoma metastases in segment 7 (a) shown by the pre-operative contrast-enhanced MR (a). Selective bland embolization was performed under fluoroscopic guidance (b, c, d). The embolic agent facilitated tumor identification on the CT (e) and contributed to the guidance of the ablation probe under CT fluoroscopy (f). The probe treatment position was confirmed by a last CT before ablation (g). CT follow-up after 5 days show satisfying ablation margins (h)